Guided Therapeutics (GTHP) Enterprise Value (2010 - 2025)

Guided Therapeutics recorded quarterly Enterprise Value of -$63000.0 in Q4 2025, up 27.59% quarter-over-quarter from -$87000.0 in Q3 2025, and up 83.76% year-over-year from -$34283.3 in Q4 2024.

Guided Therapeutics' Enterprise Value history runs 16 years deep, the most recent figure standing at -$63000.0 for Q4 2025.

  • In Q4 2025, Enterprise Value rose 83.76% year-over-year to -$63000.0; the TTM figure through Dec 2025 stood at -$63000.0 (up 83.76% YoY), while the FY2025 annual figure was -$63000.0, up 83.76% from the prior year.
  • Enterprise Value came in at -$63000.0 for Q4 2025 at Guided Therapeutics, up from -$87000.0 in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$63000.0 in Q4 2025 to a low of -$2.7 million in Q3 2022.
  • A 5-year average of -$790150.0 and a median of -$566000.0 in 2021 frame the typical range for Enterprise Value.
  • Across the five-year window, Enterprise Value sank 5838.1% in 2021 and soared 83.76% in 2025, its largest moves.
  • Guided Therapeutics' Enterprise Value stood at -$643000.0 in 2021, then tumbled by 259.72% to -$2.3 million in 2022, then surged by 74.45% to -$591000.0 in 2023, then surged by 34.35% to -$388000.0 in 2024, then jumped by 83.76% to -$63000.0 in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$63000.0, -$87000.0, and -$185000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.66 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -2.88 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -8.17 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -1.21 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -3.67 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -3.09 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -1.12 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.07 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -426.00 Mn
10 Guided Therapeutics - - 458,000.00 -63,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -63,000.00
Sep 30, 2025 -87,000.00
Jun 30, 2025 -185,000.00
Mar 31, 2025 -115,000.00
Dec 31, 2024 -388,000.00
Sep 30, 2024 -194,000.00
Jun 30, 2024 -275,000.00
Mar 31, 2024 -445,000.00
Dec 31, 2023 -591,000.00
Sep 30, 2023 -731,000.00
Jun 30, 2023 -1.36 Mn
Mar 31, 2023 -1.84 Mn
Dec 31, 2022 -2.31 Mn
Sep 30, 2022 -2.70 Mn
Jun 30, 2022 -446,000.00
Mar 31, 2022 -725,000.00
Dec 31, 2021 -643,000.00
Sep 30, 2021 -541,000.00
Jun 30, 2021 -922,000.00
Mar 31, 2021 -1.25 Mn
Dec 31, 2020 -182,000.00
Sep 30, 2020 -581,000.00
Jun 30, 2020 -763,000.00
Mar 31, 2020 -21,000.00
Dec 31, 2019 -899,000.00
Mar 31, 2019 -6,000.00
Sep 30, 2018 -70,000.00
Jun 30, 2018 -41,000.00
Mar 31, 2018 -76,000.00
Dec 31, 2017 -1,000.00
Sep 30, 2017 -74,000.00
Jun 30, 2017 -8,000.00
Mar 31, 2017 -1,000.00
Dec 31, 2016 -14,000.00
Sep 30, 2016 -4,000.00
Jun 30, 2016 -22,000.00
Mar 31, 2016 -56,000.00
Dec 31, 2015 -35,000.00
Sep 30, 2015 -172,000.00
Jun 30, 2015 -1.97 Mn
Mar 31, 2015 -18,000.00
Dec 31, 2014 -162,000.00
Sep 30, 2014 -42,000.00
Jun 30, 2014 -485,000.00
Mar 31, 2014 -50,000.00
Dec 31, 2013 -613,000.00
Sep 30, 2013 -400,000.00
Jun 30, 2013 -1.98 Mn
Mar 31, 2013 -1.11 Mn
Dec 31, 2012 -1.05 Mn
Sep 30, 2012 -2.51 Mn
Jun 30, 2012 -1.34 Mn
Mar 31, 2012 -900,000.00
Dec 31, 2011 -2.10 Mn
Sep 30, 2011 -1.13 Mn
Jun 30, 2011 -2.34 Mn
Mar 31, 2011 -2.31 Mn
Dec 31, 2010 -3.16 Mn
Jun 30, 2010 -373,000.00